Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Increasing the Treatment Success Rate of Tuberculosis in a Private Hospital through Public-Private Mix (PPM) Project

공공민간협력사업을 통한 한 민간병원의 결핵치료 성공률 향상

  • Park, Jae-Seuk (Department of Internal Medicine, Dankook University College of Medicine)
  • 박재석 (단국대학교 의과대학 내과학교실)
  • Received : 2010.08.30
  • Accepted : 2010.12.02
  • Published : 2011.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Stopping medical treatment by tuberculosis (TB) patients prior to completing treatment period is a major concern in private hospitals. We evaluated the impact of public-private mix (PPM) project on increasing treatment success rate of TB in a private tertiary hospital in Korea. Methods: Starting in February 2009, TB patients treated at Dankook University Hospital received health education and case monitoring activities by specially trained public health nurses (PPM project). On a retrospective basis, we reviewed medical records and compared the treatment outcome of TB patients treated under the PPM project (PPM group) to patients treated without the PPM project (control group) between January 2008 and June 2010. In addition, we also evaluated the risk factors treatment non-completion. Results: The number of patients in the PPM group and control group were 123 (85 pulmonary TB and 38 extrapulmonary TB) and 146 (101 pulmonary TB and 45 extra-pulmonary TB), respectively. The PPM group had demographic and clinical findings comparable to those of control group. The PPM group showed a significantly higher treatment success rate (93.5%) compared to the control group (77.9%). However, development of complications, proximity to the hospital, and presence of co-morbid disease did not influence the treatment success rate. Conclusion: The PPM project was effective at increasing the TB treatment success rate. An effort to improve and to expand the PPM project is needed in private Korean hospitals.

Keywords

References

  1. Korea Center for Disease Control and Prevention, Korean institute of tuberculosis. Annual report on the notified tuberculosis patients in Korea: based on Korean tuberculosis surveillance system. Seoul: Korea Center for Disease Control and Prevention; 2007.
  2. Koh WJ, Kwon OJ. Treatment of tuberculosis patients in the private sector in Korea. Tuberc Respir Dis 2004;56:443-9. https://doi.org/10.4046/trd.2004.56.5.443
  3. Hong YP, Kim SJ, Lew WJ, Lee SH, Lee EK. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994. Int J Tuberc Lung Dis 1998;2:365-71.
  4. Hong YP, Kim SJ, Lee EG, Lew WJ, Bai JY. Treatment of bacillary pulmonary tuberculosis at the chest clinics in the private sector in Korea, 1993. Int J Tuberc Lung Dis 1999;3:695-702.
  5. Lonroth, K. Public-private mix for dots: global progress--report. World Health Organization: WHO/HTM/TB, 338. Geneva: World Health Organization Stop TB department; 2004.
  6. Kim HJ, Bai GH, Kang MK, Kim SJ, Lee JK, Cho SI, et al. A public-private collaboration model for treatment intervention to improve outcomes in patients with tuberculosis in the private sector. Tuberc Respir Dis 2009;66:349-57. https://doi.org/10.4046/trd.2009.66.5.349
  7. Jung YJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, et al. The clinical characteristics, diagnosis, treatment and outcomes of patients with tuberculosis at a private university hospital in Korea. Tuberc Respir Dis 2006; 60:194-204. https://doi.org/10.4046/trd.2006.60.2.194
  8. Rhee CW, Han CH, Lim SA, Cho HJ. Compliance with anti-tuberculosis therapy of pulmonary tuberculosis patients. J Korean Acad Fam Med 2000;21:684-92.
  9. Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis 2002;6:573-9.
  10. Chuah SY. Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia. Tubercle 1991;72:261-4. https://doi.org/10.1016/0041-3879(91)90051-S
  11. Erhabor GE, Aghanwa HS, Yusuph M, Adebayo RA, Arogundade FA, Omidiora A. Factors influencing compliance in patients with tuberculosis on directly observed therapy at Ile-Ife, Nigeria. East Afr Med J 2000;77:235-9.

Cited by

  1. Korean Guidelines for the Treatment of Tuberculosis vol.82, pp.3, 2012, https://doi.org/10.3904/kjm.2012.82.3.269
  2. Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen vol.108, pp.4, 2011, https://doi.org/10.1016/j.rmed.2014.01.010
  3. 전국 결핵 신환자 의료빅데이터를 이용한 경쟁위험모형 적합 vol.31, pp.4, 2018, https://doi.org/10.5351/kjas.2018.31.4.529
  4. Early Discontinuation of Ethambutol in Pulmonary Tuberculosis Treatment Based on Results of the GenoType MTBDRplus Assay: a Prospective, Multicenter, Noninferiority Randomized Trial in South Korea vol.63, pp.12, 2011, https://doi.org/10.1128/aac.00980-19